4.7 Article

A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Factor H-related protein 1: a complement regulatory protein and guardian of necrotic-type surfaces

Christine Skerka et al.

Summary: FHR-1, a member of the factor H protein family, plays a crucial role in regulating innate immune complement reactions. Recent studies have shown its involvement in various diseases and potential role in inflammation induced by necrosis. This review provides insights into the role of FHR-1 in pathology and identifies it as a potential therapeutic target for inflammatory diseases.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Immunology

Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade

A. Vitiello et al.

Summary: This passage discusses the novel coronavirus SARS-CoV-2 and the ongoing global pandemic COVID-19, highlighting the importance of understanding the immunological and inflammatory processes of the infection. It also emphasizes the significance of pharmacological approaches to regulating the uncontrolled inflammatory/immunologic response in severe cases of COVID-19 infection.

HUMAN IMMUNOLOGY (2021)

Article Immunology

COVID-19 convalescent plasma composition and immunological effects in severe patients

Yeny Acosta-Ampudia et al.

Summary: Convalescent plasma treatment for severe COVID-19 patients showed improvement in immune response and metabolic status, suggesting promising therapeutic implications for further studies.

JOURNAL OF AUTOIMMUNITY (2021)

Article Biology

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression

Andre F. Rendeiro et al.

Summary: A study on COVID-19 patients found dynamic changes in innate and adaptive immune cells during disease progression, with significant absolute changes in lymphocyte and myeloid cells in severe cases. Intubation and death were associated with selected natural killer cell KIR receptor usage and IgM+ B cells, along with profound CD4 and CD8 T-cell exhaustion.

LIFE SCIENCE ALLIANCE (2021)

Review Virology

Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics

Jenifer Kiem Aviani et al.

Summary: CPT has shown potential benefits in treating COVID-19 and other viral respiratory diseases, with reduced mortality and increased number of discharged patients. Current studies suggest that CPT may act by rapidly reducing viral titers, but further large-scale randomized controlled studies are needed for validation.

REVIEWS IN MEDICAL VIROLOGY (2021)

Article Physiology

Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort

Morayma Reyes Gil et al.

Summary: This study investigated the coagulopathic presentation of COVID-19 in New York during the early stages of the pandemic surge, focusing on the relationship between hematologic and coagulation parameters and mortality. The results showed that admission PT, ANC, and first D-Dimer could differentiate between patients who were discharged alive and those who died, with an increased odds ratio for mortality associated with higher first D-Dimer levels within 48 hours of admission. The study also identified the optimal cut-point for initial D-Dimer to predict mortality as 2.1 µg/mL.

FRONTIERS IN PHYSIOLOGY (2021)

Article Immunology

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System

Miklos Lipcsey et al.

Summary: Severe COVID-19 can lead to ARDS-like lung injury associated with vascular inflammation, thrombosis, and angiogenesis, in which the intravascular innate immune system (IIIS) plays a crucial role. Activation of blood cascade systems in critically ill COVID-19 patients is linked to organ damage, illness severity scores, and survival, suggesting potential prognostic markers and therapeutic targets for the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, General & Internal

Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis

Johannes Gratz et al.

Summary: This study aimed to summarize the incidence of clinically relevant venous thromboembolism (VTE) in critically ill patients with COVID-19. The results showed lower incidence rates than previously reported, providing important clinical information for individual risk-benefit assessments.

FRONTIERS IN MEDICINE (2021)

Review Pharmacology & Pharmacy

Complement, inflammation and thrombosis

Elias Rawish et al.

Summary: This review explores the mutual relationship between immune activation and thrombus formation mechanisms, particularly focusing on how the complement system can modulate platelet activation. While some components of the complement system have been associated with platelets and shown to be functionally active in the micromilieu of platelet activation, the exact regulatory mechanisms and the consequences on tissue inflammation, damage, or recovery are still to be fully understood.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Immunology

Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis

Tyler J. Loftus et al.

Summary: Both bacterial sepsis and SARS-CoV-2 patients showed significant immune suppression and inflammation through 21 days, but their immune dyscrasia temporal patterns and clinical outcomes were different. SARS-CoV-2 patients had less severe early inflammation and organ dysfunction, but persistent inflammation and immunosuppression, leading to worse clinical outcomes, especially when followed by secondary bacterial infection.

FRONTIERS IN IMMUNOLOGY (2021)

Article Allergy

C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia

Wilfried Posch et al.

Summary: The study found that SARS-CoV-2 infection leads to excessive local C3 mobilization in primary human bronchial and small airway epithelial cells, resulting in exaggerated intracellular complement activation, destruction of epithelial integrity, and secretion of significantly higher levels of C3a and proinflammatory cytokines.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Hematology

Mechanisms of thrombosis and cardiovascular complications in COVID-19

Eden M. Page et al.

Summary: COVID-19 disease is characterized by interactions between hyperactive coagulation and complement systems, resulting in a pro-thrombotic state and tissue injury. D-dimer is the most significant prognostic marker of disease severity, with the presence of thrombocytopenia being a key indicator of patient deterioration. Further research is needed to understand the underlying pathophysiology in COVID-19 and the potential implications for disease progression and patient management.

THROMBOSIS RESEARCH (2021)

Article Immunology

SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation

Bingyu Yan et al.

Summary: Patients with COVID-19 present a wide range of acute clinical manifestations, affecting the lungs, liver, kidneys, and gut. Research has found that SARS-CoV-2 infection induces high activation of the complement system intracellularly in respiratory epithelial cells, with distinct complement activation signatures in cells from patients. Combination therapy with JAK inhibitors and drugs that normalize NF-kappa B signaling could potentially have clinical application for severe COVID-19 patients, by inhibiting C3a production.

SCIENCE IMMUNOLOGY (2021)

Review Medicine, General & Internal

Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis

Changgang Wu et al.

Summary: Critically ill patients with COVID-19 have a high prevalence of VTE, despite the use of present routine prophylactic anticoagulation.

FRONTIERS IN MEDICINE (2021)

Article Medical Laboratory Technology

Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19

Claus Lohman Brasen et al.

Summary: The study found that the amount of antigen produced in the body during a COVID-19 infection is closely related to the concentration of viral RNA, which in turn affects the degree of inflammation, need for respiratory support, and mortality. This research provides valuable information for predicting disease severity, outcome, and viral clearance.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Cell Biology

A distinct innate immune signature marks progression from mild to severe COVID-19

Stephane Chevrier et al.

Summary: This study used mass cytometry and targeted proteomics to analyze the innate immune responses of patients with mild or severe COVID-19 and healthy individuals, revealing different immune response dynamics at different stages of the disease.

CELL REPORTS MEDICINE (2021)

Review Clinical Neurology

Stroke in COVID-19: A systematic review and meta-analysis

Stefania Nannoni et al.

Summary: Acute cerebrovascular diseases occur in 1.4% of COVID-19 patients, with acute ischemic stroke being the most common manifestation. Patients with COVID-19 are more likely to have pre-existing vascular risk factors and higher mortality rates compared to those without cerebrovascular diseases.

INTERNATIONAL JOURNAL OF STROKE (2021)

Editorial Material Medicine, General & Internal

Convalescent Plasma to Treat COVID-19 Possibilities and Challenges

John D. Roback et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes

Lejla Alic et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Urology & Nephrology

The case of complement activation in COVID-19 multiorgan impact

Marina Noris et al.

KIDNEY INTERNATIONAL (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Yan Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Pathology

Complement Membrane Attack Complex New Roles, Mechanisms of Action, and Therapeutic Targets

Catherine B. Xie et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

Article Medicine, Research & Experimental

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Kenneth E. Remy et al.

JCI INSIGHT (2020)

Article Virology

Can steroids reverse the severe COVID-19 induced cytokine storm?

Lykourgos Kolilekas et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

A. B. Cavalcanti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Medicine, General & Internal

Corticosteroids in COVID-19 ARDS Evidence and Hope During the Pandemic

Hallie C. Prescott et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Pharmacology & Pharmacy

Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration

Matteo Stravalaci et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Endocrinology & Metabolism

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Awadhesh Kumar Singh et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Medicine, General & Internal

Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment

Kenneth K. Ng et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Biochemistry & Molecular Biology

Complement factor H in host defense and immune evasion

Raffaella Parente et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Review Immunology

Complement in removal of the dead - balancing inflammation

Myriam Martin et al.

IMMUNOLOGICAL REVIEWS (2016)

Review Immunology

Resolution of inflammation: what Controls its Onset?

Michelle A. Sugimoto et al.

FRONTIERS IN IMMUNOLOGY (2016)

Article Medicine, General & Internal

Sepsis and septic shock

Richard S. Hotchkiss et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Biochemistry & Molecular Biology

APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction

Ileana Soto et al.

PLOS BIOLOGY (2015)

Review Immunology

The role of C5a in acute lung injury induced by highly pathogenic viral infections

Renxi Wang et al.

EMERGING MICROBES & INFECTIONS (2015)

Article Immunology

Changes and Regulation of the C5a Receptor on Neutrophils during Septic Shock in Humans

Heike Unnewehr et al.

JOURNAL OF IMMUNOLOGY (2013)

Review Immunology

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

Ulf Andersson et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)

Article Emergency Medicine

The Glue Grant experience: characterizing the post injury genomic response

A. G. Cuenca et al.

EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY (2011)

Review Biochemistry & Molecular Biology

HMGB1, a potent proinflammatory cytokine in sepsis

Wenchang Huang et al.

CYTOKINE (2010)

Article Biochemistry & Molecular Biology

Annexin-II, DNA, and Histones Serve as Factor H Ligands on the Surface of Apoptotic Cells

Jonatan Leffler et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels

Kathy Klos et al.

HUMAN MOLECULAR GENETICS (2008)

Article Biochemistry & Molecular Biology

The extracellular matrix and inflammation -: Fibromodulin activates the classical pathway of complement by directly binding C1q

A Sjöberg et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Health Care Sciences & Services

Evaluation of Charlson's comorbidity index in elderly living in nursing homes

F Buntinx et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)

Article Biochemistry & Molecular Biology

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids

B Garner et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)